Pfizer Inc (MIL:1PFE)
€ 24.625 -0.16 (-0.65%) Market Cap: 138.78 Bil Enterprise Value: 192.52 Bil PE Ratio: 34.89 PB Ratio: 1.59 GF Score: 64/100

Pfizer Inc at Truist BioPharma Symposium Transcript

Nov 09, 2023 / 05:35PM GMT
Robyn Kay Shelton Karnauskas
Truist Securities, Inc., Research Division - Research Analyst

All right. Good afternoon. Thanks so much for joining us. I'm Robyn Karnauskas, one of the biotech analysts at Truist. I'm so excited to have for a keynote this afternoon from Pfizer, Aamir Malik, the Chief Business Innovation Officer and Executive Vice President. So thank you very much for taking the time and doing this talk instead of doing more important things. I really appreciate it.

Aamir Malik
Pfizer Inc. - Executive VP & Chief Business Innovation Officer

It's nice to be with you. Thanks for having me.

Questions & Answers

Robyn Kay Shelton Karnauskas;Aamir Malik
Truist Securities, Inc., Research Division - Research Analyst;Pfizer Inc. - Executive VP

So I guess the first question is, given your role as the Chief Business Innovation Officer, how do you see Pfizer's approach to innovation compared to other pharma companies? And how does Pfizer think about this differently?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot